Lehrstuhl für Geburtshilfe und Frauenheilkunde


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study (2023) Burghaus S, Drazic P, Wölfler M, Mechsner S, Zeppernick M, Meinhold-Heerlein I, Mueller MD, et al. Journal article Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel (2023) Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, et al. Journal article S1 Guideline: Impairment of gonadal function after Cancer in Childhood and Adolescence (2023) Borgmann-Staudt A, Jantke A, Hinz S, Beckmann M, Dittrich R, Lotz L, Balcerek M Journal article Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer (2023) Slamon DJ, Fasching P, Hurvitz S, Chia S, Crown J, Martín M, Barrios CH, et al. Journal article Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study (2023) Curigliano G, Dunton K, Rosenlund M, Janek M, Cathcart J, Liu Y, Fasching P, Iwata H Journal article Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients (2023) Tzschaschel M, Friedl TW, Schochter F, Schütze S, Polasik A, Fehm T, Pantel K, et al. Journal article Beeinträchtigung der Gonadenfunktion nach Chemo- und Strahlentherapie im Kindes- und Jugendalter: Handlungsempfehlungen nach der S1 Leitlinie (2023) Borgmann-Staudt A, Jantke A, Hinz S, Beckmann M, Dittrich R, Lotz L, Balcerek M Journal article Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States (2023) Huang M, Fasching P, Haiderali A, Xue W, Yang C, Pan W, Zhou ZY, et al. Journal article Orofacial clefts alter early life oral microbiome maturation towards higher levels of potentially pathogenic species: A prospective observational study (2023) Seidel CL, Strobel K, Weider M, Tschaftari M, Unertl C, Willershausen I, Weber M, et al. Journal article Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable (2023) Bauer M, Hildebrand L, Rosahl MC, Erber R, Schnellhardt S, Büttner-Herold M, Putz F, et al. Journal article